sorafenib has been researched along with Cyst in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fabris, L; Ferrero, C; Fiorotto, R; Kim, AK; Locatelli, L; Morell, CM; Okolicsanyi, S; Spirli, C; Strazzabosco, M | 1 |
1 other study(ies) available for sorafenib and Cyst
Article | Year |
---|---|
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib.
Topics: Animals; Antineoplastic Agents, Hormonal; Benzenesulfonates; Bile Ducts; Caspase 3; Cell Proliferation; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Cysts; Drug Therapy, Combination; Epithelial Cells; Ki-67 Antigen; Liver Diseases; MAP Kinase Signaling System; Mice; Mice, Knockout; Niacinamide; Octreotide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Pyridines; Sorafenib; TRPP Cation Channels | 2012 |